Axa S.A. Puma Biotechnology, Inc. Transaction History

Axa S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$9.38 - $13.63 $1.69 Million - $2.46 Million	-180,700 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.01 - $13.24 $1.27 Million - $2.39 Million	180,700 New	180,700 $1.89 Million
Q2 2018 Aug 13, 2018	SELL	$48.3 - $68.25 $1.03 Million - $1.45 Million	-21,314 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$59.7 - $99.25 $636,819 - $1.06 Million	10,667 Added 100.19%	21,314 $1.45 Million
Q4 2017 Feb 13, 2018	BUY	$93.85 - $132.45 $999,220 - $1.41 Million	10,647	10,647 $1.05 Million

110

28.3M

27.9K

3.4K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $155M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.